Back to search
FDAFDA · Food and drugs·Recall number D-0756-2021

Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile, Rx Only, For Intravenous Infusion Only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089. NDC 70594-036-01

Published September 1, 2021 · Recall initiated: August 6, 2021

Summary

FDA records drug Class II recall D-0756-2021, published September 1, 2021 and initiated August 6, 2021. Recalling firm: XELLIA PHARMACEUTICALS USA, LLC; Status: Terminated; Reported quantity: 9,161 vials 50 mg and 100 mg vials total; Lot: Lot 467111, exp 1/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
XELLIA PHARMACEUTICALS USA, LLC
Distributor
Nationwide USA
Lot
Lot 467111, exp 1/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile, Rx Only, For Intravenous Infusion Only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089. NDC 70594-036-01 recalled?

Yes. FDA published recall D-0756-2021 on September 1, 2021. Reported hazard: Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

What should I do if I have this product?

Voluntary: Firm initiated · Letter